GLA c.146G>C ;(p.R49P)

Variant ID: X-100662746-C-G

NM_000169.2(GLA):c.146G>C;(p.R49P)

This variant was identified in 8 publications

View GRCh38 version.




Publications:


The Interaction of Innate and Adaptive Immunity and Stabilization of Mast Cell Activation in Management of Infusion Related Reactions in Patients with Fabry Disease.

International Journal Of Molecular Sciences
Limgala, Renuka P RP; Fikry, Jaqueline J; Veligatla, Vasudha V; Goker-Alpan, Ozlem O
Publication Date: 2020-09-29

Variant appearance in text: GLA: R49P
PubMed Link: 33003611
Variant Present in the following documents:
  • Main text
  • ijms-21-07213.pdf
View BVdb publication page



Fabry disease screening in high-risk populations in Japan: a nationwide study.

Orphanet Journal Of Rare Diseases
Yoshida, Shinichiro S; Kido, Jun J; Sawada, Takaaki T; Momosaki, Ken K; Sugawara, Keishin K; Matsumoto, Shirou S; Endo, Fumio F; Nakamura, Kimitoshi K
Publication Date: 2020-08-26

Variant appearance in text: GLA: 146G>C
PubMed Link: 32843101
Variant Present in the following documents:
  • 13023_2020_Article_1494.pdf
View BVdb publication page



Correlation between GLA variants and alpha-Galactosidase A profile in dried blood spot: an observational study in Brazilian patients.

Orphanet Journal Of Rare Diseases
Varela, Patrícia P; Mastroianni Kirsztajn, Gianna G; Motta, Fabiana L FL; Martin, Renan P RP; Turaça, Lauro T LT; Ferrer, Henrique L F HLF; Gomes, Caio P CP; Nicolicht, Priscila P; Mara Marins, Maryana M; Pessoa, Juliana G JG; Braga, Marion C MC; D'Almeida, Vânia V; Martins, Ana Maria AM; Pesquero, João B JB
Publication Date: 2020-01-29

Variant appearance in text: GLA: 146G>C; R49P; rs398123205
PubMed Link: 31996269
Variant Present in the following documents:
  • Main text
  • 13023_2019_Article_1274.pdf
View BVdb publication page



Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports
Šimčíková, Daniela D; Heneberg, Petr P
Publication Date: 2019-12-09

Variant appearance in text: GLA: R49P
PubMed Link: 31819097
Variant Present in the following documents:
  • 41598_2019_54976_MOESM2_ESM.xlsx, sheet 8
View BVdb publication page



Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta.

American Journal Of Translational Research
Limgala, Renuka P RP; Jennelle, Tabitha T; Plassmeyer, Matthew M; Boutin, Michel M; Lavoie, Pamela P; Abaoui, Mona M; Auray-Blais, Christiane C; Nedd, Khan K; Alpan, Oral O; Goker-Alpan, Ozlem O
Publication Date: 2019

Variant appearance in text: GLA: R49P
PubMed Link: 30972193
Variant Present in the following documents:
  • Main text
View BVdb publication page



Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases.

Plos One
Ivanova, Margarita M MM; Changsila, Erk E; Iaonou, Chidima C; Goker-Alpan, Ozlem O
Publication Date: 2019

Variant appearance in text: GLA: R49P
PubMed Link: 30633777
Variant Present in the following documents:
  • Main text
View BVdb publication page



GESPA: classifying nsSNPs to predict disease association.

Bmc Bioinformatics
Khurana, Jay K JK; Reeder, Jay E JE; Shrimpton, Antony E AE; Thakar, Juilee J
Publication Date: 2015-07-25

Variant appearance in text: GLA: R49P
PubMed Link: 26206375
Variant Present in the following documents:
  • 12859_2015_673_MOESM1_ESM.xls, sheet 2
View BVdb publication page



Comparative study of structural changes caused by different substitutions at the same residue on α-galactosidase A.

Plos One
Saito, Seiji S; Ohno, Kazuki K; Sakuraba, Hitoshi H
Publication Date: 2013

Variant appearance in text: GLA: R49P
PubMed Link: 24386359
Variant Present in the following documents:
  • Main text
  • pone.0084267.pdf
View BVdb publication page